Since then, reports have identified CD44+ cells to be enriched for CSC-like properties, CD26+ cells capable of initiating tumor formation and facilitating EMT, and LGR5+ normal intestinal SCs serving as the tumor cells of origin (Desai et al., 2019). This evidence concerns the gene DPP4 and neoplasm.